# Akso Health Group (AHG)

> Source: Nexqual · https://nexqual.com/AHG · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, Akso Health Group (AHG), nexqual.com/AHG" · informational, not investment advice.

**Price:** USD 1.22 (-3.94% on the day) · last close of Oct 22, 2026; US market pre market, not a live price. Prev close 1.27 · day 1.21–1.29 · 52w 0.68–2.5 · market cap $1.05B · NCM

## Key facts
- Analysts: None.
- Total return with dividends: 1Y -27.4% vs S&P 500 +14.9%; 5Y -78.3% vs S&P 500 +80.3%.

## Analysts
Consensus None.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-18) |
|---|---|---|
| Total return | -27.4% | -78.3% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -27.5% | -26.3% |
| Volatility (annualized) | 93.3% | 114.6% |
| Max drawdown | -72.4% (Mar 2026→Sep 2026) | -95.2% (Oct 2021→Jul 2023) |

## Peers (Medical Distribution)
HSIC (Henry Schein, Inc.) USD 86 +1.16% · CAH (Cardinal Health, Inc.) USD 255.64 -0.71% · COR (Cencora, Inc.) USD 338.48 -0.57% · MCK (McKesson Corporation) USD 1,012.34 -0.31%

## More
Full page: https://nexqual.com/AHG · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2019-09-30) | — | — | — | $0 | — |
| Next quarter | — | — | — | $0 | — |
| Current fiscal year (ends 2020-03-31) | — | — | — | $0 | — |
| Next fiscal year | — | — | — | $0 | — |